Why Is vTv Therapeutics (VTVT) Stock Down 46% Today?
Source: Minerva Studio / Shutterstock.com VTv Therapeutics (NASDAQ:VTVT) stock is falling hard on Monday after the Food and Drug Administration (FDA) placed a clinical hold on its cadisegliatin clinical program. According to a news release from the …